A prostata specifikus antigénnel szerzett tapasztalataink prostatadaganatos betegekben.

Translated title of the contribution: Experience with prostate-specific antigen in patients with prostatic cancer

Research output: Contribution to journalArticle

1 Citation (Scopus)


The authors investigated 71 prostatic cancer patients and 45 BPH patients. The serum concentration of prostatic specific antigen (PSA), the prostatic acid phosphatase (PAP) by radio-immunoassay, the same enzyme (SPP) and the total acid phosphatase (SP) by enzymatic method were determined. In the untreated cancer patients the PSA concentration proved to be pathological in a higher proportion in all stage groups comparing to the results of the PAP, SPP, SP. The clearing of the PSA and PAP concentration on the following days and months after the beginning of the therapy reflects the excellent monitoring capability of the PSA determination. This was demonstrated by several cases too. The authors suggest more frequent use of this method in clinical practice.

Original languageHungarian
Pages (from-to)2797-2800
Number of pages4
JournalOrvosi hetilap
Issue number52
Publication statusPublished - Dec 24 1989


ASJC Scopus subject areas

  • Medicine(all)

Cite this